Brief: Median Technologies says awarded new projects and contracts worth 4.09 mln euros

Median Technologies SA

13/10/2015 16:45

Oct 13 (Reuters) - Median Technologies SA  ALMDT.PA : 
    * Says awarded new projects and new contracts for image 
interpretation and management in clinical trials totaling 4.09 
million euros  ($4.65 million) 
    * Awarded projects include a phase III study (gastric 
cancer) for a total of 1.75 million euros 
    * a phase III study (rare and aggressive cutaneous cancer) 
for a total of 1.51 million euros 
    * Awarded projects include a phase II study (melanoma) for a 
total of 335,000 euros 
    * Contracts awarded include a phase I/II study (liver 
cancer) for a total of 394,000 euros 
    * Contracts awarded include a phase II study (primary 
central nervous system lymphoma) for a total of 103,000 euros 
 
     
Source text for Eikon:  ID:nBw6w3330a  
Further company coverage:  ALMDT.PA  
 
($1 = 0.8788 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))